Follow The Filings

LABT Lakewood-Amedex Biotherapeutics

Lakewood-Amedex Biotherapeutics earnings company data as of 4:48 AM ET 10/23

History

2 periods, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 12 Nov EPS — — —
Rev — — —
FY2026 Q2 13 Aug EPS 0.65 — —
Rev — — —

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
8-K 5.07
S-1 REGISTRATION STATEMENT
424B3 PROSPECTUS SUPPLEMENT
SCHEDULE 13G —
10-Q QUARTERLY REPORT
DEF 14A PROXY STATEMENT
DEFA14A DEFINITIVE ADDITIONAL MATERIALS
SCHEDULE 13G —
8-K 7.01,9.01
SCHEDULE 13G —
424B3 PROSPECTUS SUPPLEMENT
424B3 PROSPECTUS SUPPLEMENT
8-K 3.03,5.03,9.01
424B3 PROSPECTUS SUPPLEMENT
424B3 PROSPECTUS SUPPLEMENT
10-Q QUARTERLY REPORT
424B4 PROSPECTUS
S-1 REGISTRATION STATEMENT
424B3 PROSPECTUS SUPPLEMENT
8-K 5.02,9.01
424B4 PROSPECTUS
S-1/A REGISTRATION STATEMENT
S-1/A REGISTRATION STATEMENT
S-1/A REGISTRATION STATEMENT
S-1/A REGISTRATION STATEMENT

Insider forms

Forms 3, 4 and 5 from EDGAR, 3 rows shown

Filed Form Detail Links
3 Period Apr 24, 2026
4 Period Apr 24, 2026
3 Period Apr 17, 2026 (3 forms)

1 more insider forms

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.